Evaluating QbMobile Device to Identify Symptom Profiles in ADHD and Related Disorders in Children, Teens, and Adults

What this Trial Is About

Researchers are evaluating the performance of QbMobile, a digital software application, in children, adolescents, and adults aged 6 to 60 years who are assessed for or diagnosed with Autism Spectrum Disorder ASD, Major Depressive Disorder MDD, Bipolar Disorder, or various Anxiety Disorders. The study aims to identify specific symptom profiles common with ADHD by collecting objective data through QbMobile tests. Participants must not currently be receiving treatment for these conditions. Participants will complete two 10-minute QbMobile tests that measure cognitive performance and activity levels. The first test is done on a personal device during a clinical visit, and the second test is completed remotely the following day at the same time as the initial test, with a three-hour window allowed. QbMobile testing occurs before any new treatment begins and is non-invasive. During the study, participants undergo assessments at two visits one in-clinic and one remote. Researchers collect data from the QbMobile tests to analyze domain profiles, classification accuracy, and variability using scores such as domain SD-scores and a total score ranging from 0 to 100. These measures help differentiate symptom profiles related to the included disorders. The study also compares results with normative datasets and includes exploratory analyses. Participation lasts until both tests are completed, with close monitoring of test performance.

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms